NIH R01 · 2024
Project Summary Methods to characterize patients who highly benefit on multiple clinical outcomes, from treatments in Alzheimer's disease and related dementias (ADRD), are necessary to treat patients effectively. Treatments may benefit some patients on targeted outcomes, but harm some patients on other, e.g., cognitive, outcomes. So, characterizing patients who highly benefit on multiple outcomes is significant: first it allows these patients to choose a treatment if it is predicted to give them high benefits without the harms; second, accurate characterization methods do not exist. Generally, a characterization method has two stages. One stage “constructs” outcome predictions based on patients'…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.